Does lung transplantation confer a survival benefit?

Current Opinion in Organ Transplantation

Volumn 14, Issue 5, 2009, Pages 499-503

  Kotloff, Robert M ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chronic obstructive pulmonary disease; Cystic fibrosis; Idiopathic pulmonary fibrosis; Lung transplantation; Survival analysis

Indexed keywords

ARTHROPATHY; BURKHOLDERIA CEPACIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; HOSPITAL ADMISSION; HUMAN; LUNG TRANSPLANTATION; QUALITY OF LIFE; REVIEW; SIMULATION; STATISTICAL MODEL; SURVIVAL; TREATMENT OUTCOME;

GRAFT REJECTION; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; PROGNOSIS; SURVIVAL RATE; UNITED STATES;

EID: 73349135296     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32832fb9f8     Document Type: Review

References (23)

1. Christie JD, Edwards LB, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report-2008. J Heart Lung Transplant 2008; 27:957-969. This is the most recent iteration of the international registry and contains detailed information on survival outcomes.
2. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. J Heart Lung Transplant 2001; 20:935-941.
3. Thabut G, Christie JD, Ravaud P, et al. Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet 2008; 371:744-751.
4. Meyer DM, Edwards LB, Torres F, et al. Impact of recipient age and procedure type on survival after lung transplantation for pulmonary fibrosis. Ann Thorac Surg 2005; 79:950-957.
5. Liou TG, Adler FR, Fitzsimmons SC, et al. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001; 153:345-352.
6. Mayer-Hamblett N, Rosenfeld M, Emerson J, et al. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med 2002; 166:1550-1555.
7. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005-1012.
8. Martinez FJ, Foster G, Curtis JL, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173:1326-1334.
9. De Meester J, Smits JM, Persijn GG, Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001; 20:518-524.
10. Charman SC, Sharples LD, McNeil KD, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002; 21:226-232.
11. Hosenpud JD, Bennett LE, Keck BM, et al. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 351:24-27.
12. Liou TG, Adler FR, Cahill BC, et al. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA 2001; 286:2683-2689.
13. Liou TG, Adler FR, Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 2005; 171:1053-1059.
14. Liou TG, Adler FR, Cox DR, Cahill BC. Lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2007; 357:2143-2152.
15. Sweet SC, Aurora P, Benden C, et al. Lung transplantation and survival in children with cystic fibrosis: solid statistics-flawed interpretation. Pediatr Transplant 2008; 12:129-136. This paper offers a detailed critique of the statistical methodology employed by Liou et al. in their analysis of survival benefit of transplantation in pediatric CF patients.
16. Aurora P, Spencer H, Moreno-Galdo A. Lung transplantation in children with cystic fibrosis: a view fromEurope.AmJ Respir Crit CareMed 2008; 177:935-936. This editorial offers a critique of the Liou study of lung transplantation in pediatric CF patients and provides a contrasting view based on a study from Europe.
17. Aurora P, Whitehead B, Wade A, et al. Lung transplantation and life extension in children with cystic fibrosis. Lancet 1999; 354:1591-1593. (Pubitemid 29515950)
18. Aurora P, Edwards LB, Christie J, et al. Registry of the International Society for Heart and Lung Transplantation: eleventh official pediatric lung and heart/lung transplantation report-2008. J Heart Lung Transplant 2008; 27:978-983.
19. Thabut G, Ravaud P, Christie JD, et al. Determinants of the survival benefit of lung transplantation in patients with chronic obstructive lung disease. Am J Respir Crit Care Med 2008; 177:1156-1163. The authors of this study have developed statistical models to predict wait list and posttransplant survival of COPD patients. Their analysis provides insight on factors that influence the likelihood that lung transplantation will extend survival in this patient population.
20. Thabut G, Mal H, Castier Y, et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg 2003; 126:469-475.
21. Davis SQ, Garrity ER Jr. Organ allocation in lung transplant. Chest 2007; 132:1646-1651.
22. McCurry KR, Shearon TH, Edwards LB, et al. Lung transplantation in the United States, 1998-2007. Am J Transplant 2008; 9:942-958. This paper provides a summary of data from the 2008 Organ Procurement and Transplantation Network Annual Report of lung transplantation in the United States. It includes an analysis of the impact of the new lung allocation system on transplant outcomes and employs the LAS predictive models of pretransplant and posttransplant survival to estimate the likelihood that transplantation confers a survival benefit for specific disease categories.
23. Snyder LD, Palmer SM. Quality, quantity, or both? Life after lung transplantation. Chest 2005; 128:1086-1087.